Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accelerated tumor progression after COVID-19 infection in patients with glioblastoma: A retrospective case-control study.
Gregory TA, Knight SR, Aaroe AE, Highsmith KN, Janatpour ZC, O'Brien BJ, Majd NK, Loghin ME, Patel CB, Weathers SP, Puduvalli VK, Kamiya-Matsuoka C. Gregory TA, et al. Among authors: patel cb. Neurooncol Pract. 2024 Apr 8;11(4):475-483. doi: 10.1093/nop/npae029. eCollection 2024 Aug. Neurooncol Pract. 2024. PMID: 39006516 Free article.
Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches.
Beckham TH, Rooney MK, McAleer MF, Ghia AJ, Tom MC, Perni S, McGovern S, Grosshans D, Chung C, Wang C, De B, Swanson T, Paulino A, Jiang W, Ferguson S, Patel CB, Li J, Yeboa DN. Beckham TH, et al. Among authors: patel cb. Neurooncol Pract. 2024 Jan 18;11(3):266-274. doi: 10.1093/nop/npae004. eCollection 2024 Jun. Neurooncol Pract. 2024. PMID: 38737610 Free article.
National Brain Tumour Registry of China (NBTRC) statistical report of primary brain tumours diagnosed in China in years 2019-2020.
Xiao D, Yan C, Li D, Xi T, Liu X, Zhu D, Huang G, Xu J, He Z, Wu A, Ma C, Long J, Shu K, Ji H, Wang N, Chen G, Yang J, Ma H, Li Z, Sun X, Qu Y, Liu Z, Jiang X, Tian C, Ni S, Zhan R, Chen L, Ge M, Wang M, Jiang X, Guo G, Han Z, Zhang C, Zhang T, Dou C, Chu L, Wang P, Shao J, Wu X, Yu J, Wang Y, Wu N, Zhang R, Zhang M, Hong Y, Gao J, Li Y, Pan Y, Zhao B, Ji N, Shan G, Patel CB, Jia W, Zhang L. Xiao D, et al. Among authors: patel cb. Lancet Reg Health West Pac. 2023 Feb 21;34:100715. doi: 10.1016/j.lanwpc.2023.100715. eCollection 2023 May. Lancet Reg Health West Pac. 2023. PMID: 37283963 Free PMC article.
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
309 results